Elevance Health (ELV) Operating Expenses (2009 - 2026)

Elevance Health (ELV) has reported Operating Expenses for 18 consecutive years, with $48.5 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Expenses rose 2.22% year-over-year to $48.5 billion in Q2 2026; TTM through Jun 2026 was $195.3 billion, a 7.19% increase from a year earlier, with the FY2025 full-year figure at $192.4 billion, up 13.78% from the prior year.
• Operating Expenses was $48.5 billion for Q2 2026 at Elevance Health, up from $47.9 billion in the prior quarter.
• Over five years, Operating Expenses peaked at $49.5 billion in Q4 2025 and troughed at $35.8 billion in Q1 2022.
• A 5-year average of $42.8 billion and a median of $41.4 billion in 2023 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses gained 18.47% in 2022 and slipped 0.8% in 2024, its largest moves.
• Over 5 years, Operating Expenses stood at $38.9 billion in 2022, then advanced by 7.1% to $41.6 billion in 2023, then increased by 7.66% to $44.8 billion in 2024, then grew by 10.47% to $49.5 billion in 2025, then retreated by 2.01% to $48.5 billion in 2026.
• The last three Operating Expenses figures came in at $48.5 billion (Q2 2026), $47.9 billion (Q1 2026), and $49.5 billion (Q4 2025), per Business Quant data.